ArticleAntioxidants (Basel, Switzerland)2023

Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE Pathway.

Sarah Naguib et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.